Agilent Technologies, Inc. - Diagnostics and Genomics SSEL XT CRE V2, 96 auto
The Agilent SureSelect XT CRE V2, 96 samples, automated (part number 5190-9493) is a targeted enrichment solution designed for comprehensive coverage of cancer-related exons. This kit enables high-throughput, automated library preparation and target enrichment for next-generation sequencing (NGS) applications. It is optimized for use with automated liquid handling platforms, supporting efficient processing of up to 96 samples in a single run. The SureSelect XT CRE V2 kit provides robust performance for the detection of variants in cancer research, offering high specificity and uniformity across targeted regions.